RecruitingPhase 3NCT06092957

Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

Studying Nasopharyngeal carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sun Yat-sen University
Principal Investigator
Ming-Yuan Chen, MD,PhD
Sun Yat-sen University
Intervention
Cisplatin-based induction chemotherapy(drug)
Enrollment
504 enrolled
Eligibility
18-70 years · All sexes
Timeline
2023 – 2031

Study locations (1)

Collaborators

First Affiliated Hospital, Sun Yat-Sen University · Affiliated Cancer Hospital & Institute of Guangzhou Medical University · Guangdong Provincial People's Hospital · Second Affiliated Hospital, Sun Yat-Sen University · The fifth Affiliated Hospital of Guangzhou Medcial University · Zhongshan People's Hospital, Guangdong, China · Hunan Cancer Hospital · Tongji Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06092957 on ClinicalTrials.gov

Other trials for Nasopharyngeal carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Nasopharyngeal carcinoma →

← Back to all trials